Article
Clinical Function Assignment of NAT2 Alleles by the Clinical Pharmacogenetics Implementation Consortium Pharmacogene Curation Expert Panel.
Clinical pharmacology and therapeutics - 1 Oct 2026
Tibben Bailey M, Hein David W, Whirl-Carrillo Michelle, Gaedigk Andrea, Eadon Michael T, Minchin Rodney F, Boukouvala Sotiria, Santos Adalberto Rezende, Donnelly Roseann S, Agúndez José A G, Caudle Kelly E
Abstract excerpt
NAT2 encodes arylamine N-acetyltransferase 2, a key enzyme in the phase II metabolism of arylamines and arylhydrazines. NAT2 is highly polymorphic, resulting in variable distributions of rapid and poor metabolizers across global populations. Here, we detail the process undertaken by the Clinical Pharmacogenetics Implementation Consortium (CPIC) NAT2 Pharmacogene Curation Expert Panel (PCEP) to assign clinical...
Read the complete abstract on PubMedTopics
- Arylamine N-Acetyltransferase
- Humans
- Pharmacogenetics
- Alleles
- Phenotype
